“Point in Time” Act Content
OPIOID DAMAGES AND HEALTH CARE COSTS RECOVERY ACT
[SBC 2018] CHAPTER 35
where
dms
=
the defendant's market share for the type of opioid product
from the date of the earliest opioid-related wrong committed
by that defendant to the date of trial;
dm
=
the quantity of the type of opioid product manufactured or
promoted by the defendant that is distributed or sold within
British Columbia from the date of the earliest opioid-related
wrong committed by that defendant to the date of trial;
MM
=
the quantity of the type of opioid product manufactured or
promoted by all manufacturers or wholesalers that is purchased
or dispensed within British Columbia for the purpose of
providing health care benefits from the date of the earliest
opioid-related wrong committed by the defendant to the date of
trial.
